AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+0.99%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.97B
AUM Growth
+$3.97B
(+69,239%)
Cap. Flow
+$668M
Cap. Flow
% of AUM
16.82%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
246
New
70
Increased
45
Reduced
41
Closed
51
Top Buys
| 1 |
GSK
GSK
|
$106M |
| 2 |
Freshpet
FRPT
|
$97M |
| 3 |
Ross Stores
ROST
|
$80.7M |
| 4 |
Five Below
FIVE
|
$76.2M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$54.4M |
Top Sells
| 1 |
Avalo Therapeutics
AVTX
|
$145M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$46.9M |
| 3 |
Bristol-Myers Squibb
BMY
|
$39.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$35.8M |
| 5 |
O'Reilly Automotive
ORLY
|
$31.9M |
Sector Composition
| 1 | Healthcare | 63.08% |
| 2 | Consumer Discretionary | 13.74% |
| 3 | Consumer Staples | 11.9% |
| 4 | Technology | 6.78% |
| 5 | Communication Services | 2.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Incyte
INCY
$16.5B
| $158M | 2.74% | 2,366,000 +366,000 | +18% | +$24.4M |
|
2
Supernus Pharmaceuticals
SUPN
$2.53B
| $155M | 2.7% | 4,593,004 -118,996 | -3% | -$4.03M |
|
3
PTC Therapeutics
PTCT
$3.92B
| $146M | 2.53% | 2,900,000 -396,000 | -12% | -$19.9M |
|
4
Travere Therapeutics
TVTX
$1.56B
| $144M | 2.49% | 5,836,000 +516,000 | +10% | +$12.7M |
|
5
Neurocrine Biosciences
NBIX
$13.8B
| $141M | 2.44% | 1,324,000 | – | – |
|
|
6
Freshpet
FRPT
$2.72B
| $137M | 2.38% | 2,736,000 +1,936,000 | +242% | +$97M |
|
|
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $133M | 2.3% | 1,900,000 -148,000 | -7% | -$10.3M |
|
8
Enanta Pharmaceuticals
ENTA
$180M
| $107M | 1.86% | 2,072,000 +2,000 | +0.1% | +$104K |
|
|
9
GSK
GSK
$79.9B
| $106M | 1.84% | +3,600,000 | New | +$106M |
|
|
10
Ross Stores
ROST
$48.1B
| $97.6M | 1.69% | 1,158,117 +957,849 | +478% | +$80.7M |
|
|
11
Regeneron Pharmaceuticals
REGN
$61.5B
| $93.7M | 1.63% | 136,000 -52,000 | -28% | -$35.8M |
|
|
DCPH
12
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $88.2M | 1.53% | 4,768,000 -632,000 | -12% | -$11.7M |
|
13
Pacira BioSciences
PCRX
$1.2B
| $84.7M | 1.47% | 1,592,000 +1,000,000 | +169% | +$53.2M |
|
14
Alkermes
ALKS
$4.78B
| $84.7M | 1.47% | 3,792,000 +868,000 | +30% | +$19.4M |
|
15
Madrigal Pharmaceuticals
MDGL
$9.76B
| $80.3M | 1.39% | 1,236,000 +136,000 | +12% | +$8.84M |
|
|
16
Five Below
FIVE
$8B
| $76.2M | 1.32% | +553,231 | New | +$76.2M |
|
17
lululemon athletica
LULU
$24.2B
| $73.1M | 1.27% | 261,475 +32,902 | +14% | +$9.2M |
|
|
18
O'Reilly Automotive
ORLY
$88B
| $70.5M | 1.22% | 100,261 -45,320 | -31% | -$31.9M |
|
19
Lowe's Companies
LOW
$145B
| $62.6M | 1.09% | 333,132 +195,587 | +142% | +$36.7M |
|
20
CRISPR Therapeutics
CRSP
$4.71B
| $60.4M | 1.05% | 924,000 -76,000 | -8% | -$4.97M |
|
21
Biogen
BIIB
$19.4B
| $59.8M | 1.04% | 224,000 -12,000 | -5% | -$3.2M |
|
22
Medtronic
MDT
$119B
| $58.5M | 1.01% | 724,000 -76,000 | -10% | -$6.14M |
|
23
FibroGen
FGEN
$47.8M
| $58M | 1.01% | 4,456,000 +364,000 | +9% | +$4.74M |
|
24
Kraft Heinz
KHC
$33.1B
| $55M | 0.95% | 1,650,000 +126,000 | +8% | +$4.2M |
|
|
25
Agios Pharmaceuticals
AGIO
$2.19B
| $54.4M | 0.94% | +1,924,000 | New | +$54.4M |
|